Why menadione sodium bisulfite complex remains a pet food puzzle: full analysis

Menadione sodium bisulfite complex, a synthetic source of vitamin K activity better known on labels as MSBC, has resurfaced as a pet food regulatory puzzle. A recent Truth about Pet Food article argued that the ingredient is widely used in dog and cat foods even though it is not plainly approved for pet food in the way many veterinarians, regulators, and pet parents might expect. That framing taps into a real tension: MSBC has a long history of use, but its legal pathway in pet food has been more complicated than a simple yes-or-no answer. (truthaboutpetfood.com)

The background goes back decades. FDA says menadione and MSBC are prior sanctioned vitamin K-active substances for poultry feed, meaning they were formally accepted for that use before 1958. FDA also notes that those compounds have been widely used in other animal feeds, including pet foods. That practical use, however, is not the same as having a modern, species-specific approval or AAFCO ingredient definition that clearly spells out dog and cat food use. That distinction is what has fueled recurring questions from consumer advocates and periodic concern among regulators. (fda.gov)

The issue became more urgent around 2020 and 2021, when AAFCO’s Ingredient Definitions Committee took up whether MSBC use in pet food could continue without disruption. PetfoodIndustry reported at the time that some regulators were considering enforcement based on the technical lack of formal sanction for non-poultry species, despite the absence of documented safety concerns. The practical stakes were significant: fish-based complete and balanced cat foods may need supplemental vitamin K, and AAFCO nutrient profiles specify 0.1 mg vitamin K per kg dry matter for cat diets containing more than 25% fish on a dry matter basis. (petfoodindustry.com)

To address that gap, AAFCO convened an expert panel in 2021. Its recommendation was straightforward: MSBC may be used as a safe and suitable source of vitamin K activity in food for all animals in the United States under good manufacturing and feeding practices. The panel’s report cited historical use, confidential industry feeding data, published toxicology, and a European Food Safety Authority review. It also concluded that, at intended nutritional use levels, menadione, and by extrapolation MSBC, would not be expected to cause adverse effects. (aafco.org)

That still leaves the regulatory nuance. AAFCO’s 2024 Official Publication includes MSBC in a vitamin ingredient nomenclature table used for labeling finished dog and cat foods, which helps explain why the ingredient appears on labels. But the same table explicitly says it is not meant to list every vitamin available for use in pet food and that the underlying ingredient definition must still be reviewed for the intended use. In other words, label recognition is not identical to a fully settled ingredient authorization pathway. That’s why critics continue to describe the issue as unresolved, even after AAFCO issued guidance supporting continued use. (aafco.org)

Industry coverage has generally treated the matter as a regulatory technicality rather than a newly emerging safety problem. PetfoodIndustry’s David Dzanis, DVM, PhD, DACVN, wrote in 2020 that MSBC had been used in pet foods for decades without documented safety concerns, and in 2021 reported that AAFCO’s near-term plan was guidance recommending continued use while encouraging eventual establishment of an official definition. That’s broadly consistent with FDA’s own explanation that vitamin K-active substances are used to prevent deficiency and that menadione compounds have important nutritional roles in animal diets. (petfoodindustry.com)

Why it matters: For veterinarians and nutrition professionals, the MSBC debate is really about regulatory clarity, client communication, and formulation risk. If pet parents ask whether the ingredient is “approved,” the most accurate answer is nuanced: it has longstanding use and supportive safety review, but its formal status in pet food has depended on a mix of prior sanction history, regulatory discretion, AAFCO guidance, and labeling conventions rather than a clean, modern approval pathway for every species. That distinction matters in an era when ingredient scrutiny is high and trust can turn on whether clinicians can explain both safety and legality with precision. (fda.gov)

What to watch: The next key development would be a clearer AAFCO ingredient definition or comparable regulatory action that expressly covers pet food use, which would bring the legal language into line with longstanding market practice. Until then, MSBC is likely to remain one of those ingredients that is common on labels, defensible from a nutritional and safety perspective, yet still capable of generating outsized concern because the regulatory paperwork doesn’t read as cleanly as the market reality. (petfoodindustry.com)